Tema Oncology ETF company info

What does Tema Oncology ETF do?
Tema Oncology ETF (NASDAQ:CANC) provides investors with exposure to companies actively involved in the fight against cancer. Launched in 2023, CANC invests in a diversified portfolio of global businesses focused on cancer prevention, diagnosis, treatment, and supportive care. This includes pharmaceutical companies developing innovative drugs, medical device manufacturers, and companies providing diagnostic tools and services. By investing in CANC, investors can gain potential access to the long-term growth prospects of the rapidly evolving oncology sector.
Tema Oncology ETF company media
Company Snapshot

Is Tema Oncology ETF a public or private company?

key
Ownership
Public

How many people does Tema Oncology ETF employ?

people
Employees
18

What sector is Tema Oncology ETF in?

pie chart
Sector
ETF

Where is the head office for Tema Oncology ETF?

location pin
Head Office
New York, United States

What year was Tema Oncology ETF founded?

founded flag
Year Founded
2023
What does Tema Oncology ETF specialise in?
/Investment Services /Oncology Research /Biopharmaceutical Stocks /Diversified Portfolio /Risk Management /Healthcare Industry

What are the products and/or services of Tema Oncology ETF?

Overview of Tema Oncology ETF offerings
Investment in groundbreaking cancer treatment technologies, focusing on innovative therapies.
Portfolio diversification across various oncology sectors, ensuring balanced exposure to the cancer care continuum.
Research and development funding aimed at supporting early-stage oncology companies.
Educational programs designed to increase investor awareness about oncology advancements and investment opportunities.
Strategic collaborations with biopharmaceutical companies to accelerate the development of new cancer treatments.
Sustainable investment strategies that prioritize long-term growth in the oncology field.